Orthopedic BiomaterialsMarket Revenue Size, Trends and Factors, Regional Share Analysis & Forecast Till 2028

Comments · 63 Views

Increasing prevalence of musculoskeletal diseases is one of the significant factors influencing market growth.

The global orthopedic biomaterials market is expected to reach USD 28.38 Billion by 2028, according to a new report by Reports and Data. Increasing prevalence of musculoskeletal diseases is one of the significant factors influencing market growth. Musculoskeletal diseases were the foremost reason for disability in four of the six WHO (World Health Organization) regions in 2017. In the 2017 study by Global Burden of Disease (GBD), musculoskeletal diseases were the highest contributor to worldwide disability (responsible for 16.0% of all years of life lived with disability), and lower back pain continued to be the single topmost cause of disability. While the occurrence of musculoskeletal diseases varies by diagnosis and age, 20.0%–33.0% of people worldwide live with an agonizing musculoskeletal condition. This disease is responsible for the highest share of lost workplace productivity.

Rise in the geriatric population is one of the significant factors influencing market growth. It has been estimated that by 2050 approximately 16% of the global population will be aged more than 65 years, which is expected to increase fivefold since 1950. Forecasts from the World Health Organization (WHO), United Nations (UN), and the EU commission all indicate aging as a significant challenge for society, which demands concentrated efforts to meet the requirements of the elderly. Heart disease, cancer, and stroke have been the primary chronic conditions that have had the highest impact on the geriatric population, particularly in high-income countries. Thus, the increasing prevalence of diseases in the growing geriatric population is likely to propel the growth of the market in the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/2474

Key participants include Evonik Industries AG, Zimmer Biomet, Globus Medical, Stryker, DSM Biomedical, Invibio Ltd., CAM Bioceramics BV, DePuy Synthes Inc., Matexel, and Exactech Inc., among others.

Further key findings from the report suggest

  • By material type, ceramic bioactive biomaterials contributed to the largest market share in 2020 and is likely to grow at the rate of 8.8% in the forecast period. The primary benefit of this biomaterial is that it is sturdy and chemically inert. Also, it has high compressive strength necessary for bone implants, and some ceramic materials are biodegradable.
  • By application, orthopedic implants accounted for the largest market size in 2020 and is estimated to grow at the rate of 8.6% in the forecast period.
  • By end-users, hospitals dominated the market in 2020 and is anticipated to grow at a rate of 8.5% in the period 2019-2028. The factors including well-resourced operating diagnostic rooms, higher purchasing power, existence of highly skilled healthcare professionals, and improved health coverage for hospital-based healthcare services from several private and group insurance plans, among others, are responsible for the high market share of hospitals.
  • North America held the largest market share in 2020 and is likely to grow at a rate of 8.6% in the forecast period. The market dominance of North America is owing to the presence of advanced healthcare facilities and increasing acceptance of new technologies in the region.

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/orthopedic-biomaterials-market

For the purpose of this report, Reports and Data have segmented the global orthopedic biomaterials market on the basis of material type, application, end-users, and region:

Material Type Outlook (Revenue, USD Million; 2020-2028)

  • Metallic Orthopedic Biomaterials
  • Ceramic Bioactive Biomaterials
  • Polymeric Orthopedic Biomaterials
  • Composite Orthopedic Biomaterials
  • Others

Application Outlook (Revenue, USD Million; 2020-2028)

  • Orthopedic Implants
  • Joint Reconstruction/Replacement
  • Orthobiologics
  • Visco Supplementation
  • Bio-Resorbable Tissue Fixation

End-Users Outlook (Revenue, USD Million; 2020-2028)

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Regional Outlook (Revenue, USD Million; 2020-2028)

  • North America
    • U.S
  • Europe
    • U.K
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
  • MEA

Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/2474

Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Power and Energy, and Chemicals. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Our Innovative Blogs @ https://www.reportsanddata.com/blogs

Comments